Linezolid Patent Expiration
Linezolid is used for treating microbial infections. It was first introduced by Pfizer Inc
Linezolid Patents
Given below is the list of patents protecting Linezolid, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Zyvox |
US6514529 (Pediatric) | Oxazolidinone tablet formulation |
Sep 15, 2021
(Expired) | Pfizer |
Zyvox |
US6559305 (Pediatric) | Linezolid—crystal form II |
Jul 29, 2021
(Expired) | Pfizer |
Zyvox | US6514529 | Oxazolidinone tablet formulation |
Mar 15, 2021
(Expired) | Pfizer |
Zyvox | US6559305 | Linezolid—crystal form II |
Jan 29, 2021
(Expired) | Pfizer |
Zyvox | US6559305 | Linezolid—crystal form II |
Jan 29, 2021
(Expired) | Pfizer |
Zyvox |
US5688792 (Pediatric) | Substituted oxazine and thiazine oxazolidinone antimicrobials |
May 18, 2015
(Expired) | Pfizer |
Zyvox | US5688792 | Substituted oxazine and thiazine oxazolidinone antimicrobials |
Nov 18, 2014
(Expired) | Pfizer |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Linezolid's patents.
Latest Legal Activities on Linezolid's Patents
Given below is the list recent legal activities going on the following patents of Linezolid.
Activity | Date | Patent Number |
---|---|---|
Correspondence Address Change Critical | 29 Aug, 2014 | US6559305(Litigated) |
Correspondence Address Change Critical | 28 Aug, 2014 | US6514529 |
Patent Issue Date Used in PTA Calculation Critical | 06 May, 2003 | US6559305(Litigated) |
Recordation of Patent Grant Mailed Critical | 06 May, 2003 | US6559305(Litigated) |
Issue Notification Mailed Critical | 17 Apr, 2003 | US6559305(Litigated) |
Receipt into Pubs | 07 Apr, 2003 | US6559305(Litigated) |
Application Is Considered Ready for Issue Critical | 03 Apr, 2003 | US6559305(Litigated) |
Receipt into Pubs | 02 Apr, 2003 | US6559305(Litigated) |
Receipt into Pubs | 03 Mar, 2003 | US6559305(Litigated) |
Workflow - File Sent to Contractor | 03 Mar, 2003 | US6559305(Litigated) |
Linezolid's Family Patents
Explore Our Curated Drug Screens
Linezolid Generic API Manufacturers
Several generic applications have been filed for Linezolid. The first generic version for Linezolid was by Teva Pharmaceuticals Usa and was approved on Jun 27, 2012. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Oct 10, 2024.
Given below is the list of companies who have filed for Linezolid generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Alembic.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG | tablet | Prescription | ORAL | AB | Dec 21, 2015 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
Country | City | Firm Name | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|
2. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG | tablet | Prescription | ORAL | AB | Dec 21, 2015 |
3. AMNEAL PHARMS
Amneal Pharmaceuticals has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Amneal Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG | tablet | Discontinued | ORAL | N/A | Dec 21, 2015 |
4. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG | tablet | Prescription | ORAL | AB | Apr 25, 2019 |
5. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG/300ML (2MG/ML) | solution | Prescription | INTRAVENOUS | AP | Aug 4, 2016 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
Country | City | Firm Name | ||||||
---|---|---|---|---|---|---|---|---|
India |
|
6. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG/300ML (2MG/ML) | solution | Prescription | INTRAVENOUS | AP | Mar 15, 2016 |
Manufacturing Plant Locations New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
Country | City | Firm Name | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
|
7. GATE PHARMS
Gate Pharmaceuticals has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Gate Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG | tablet | Discontinued | ORAL | N/A | Feb 5, 2016 |
8. GLENMARK SPECLT
Glenmark Specialty Sa has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG | tablet | Prescription | ORAL | AB | Dec 21, 2015 |
9. HETERO LABS
Hetero Labs Ltd has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Hetero Labs.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG/5ML | for suspension | Prescription | ORAL | AB | Oct 31, 2022 |
Manufacturing Plant Locations New
Hetero Labs's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Hetero Labs as present at those locations.
Country | City | Firm Name | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|
10. HETERO LABS LTD V
Hetero Labs Ltd Unit V has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG | tablet | Prescription | ORAL | AB | Dec 21, 2015 |
11. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Linezolid. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
100MG/5ML | for suspension | Prescription | ORAL | AB | Jun 3, 2015 |
600MG/300ML (2MG/ML) | solution | Prescription | INTRAVENOUS | AP | Aug 22, 2022 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||
Portugal |
| |||||||||
Jordan |
|
12. HOSPIRA
Hospira Inc has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Hospira.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG/300ML (2MG/ML) | solution | Discontinued | INTRAVENOUS | N/A | Jul 7, 2015 |
Manufacturing Plant Locations New
Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.
Country | City | Firm Name | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Australia |
| |||||||||||||
United States |
| |||||||||||||
Dominican Republic (the) |
|
13. HQ SPCLT PHARMA
Hq Specialty Pharma Corp has filed for 2 different strengths of generic version for Linezolid. Given below are the details of the strengths of this generic introduced by Hq Spclt Pharma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG/100ML (2MG/ML) | solution | Prescription | INTRAVENOUS | AP | Jul 7, 2017 |
600MG/300ML (2MG/ML) | solution | Prescription | INTRAVENOUS | AP | Jul 7, 2017 |
14. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG | tablet | Prescription | ORAL | AB | Oct 10, 2024 |
15. MYLAN LABS LTD
Mylan Laboratories Ltd has filed for 2 different strengths of generic version for Linezolid. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG/300ML (2MG/ML) | solution | Prescription | INTRAVENOUS | AP | Dec 6, 2017 |
200MG/100ML (2MG/ML) | solution | Prescription | INTRAVENOUS | AP | Dec 6, 2017 |
16. NANG KUANG PHARM CO
Nang Kuang Pharmaceutical Co Ltd has filed for 2 different strengths of generic version for Linezolid. Given below are the details of the strengths of this generic introduced by Nang Kuang Pharm Co.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG/100ML (2MG/ML) | solution | Prescription | INTRAVENOUS | AP | Dec 20, 2016 |
600MG/300ML (2MG/ML) | solution | Prescription | INTRAVENOUS | AP | Dec 20, 2016 |
17. NOVEL LABS INC
Novel Laboratories Inc has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Novel Labs Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG | tablet | Prescription | ORAL | AB | Aug 22, 2016 |
18. RISING
Rising Pharma Holdings Inc has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Rising.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG | tablet | Prescription | ORAL | AB | Dec 21, 2015 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
Country | City | Firm Name | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||||
Mexico |
| |||||||||||||||||||
India |
|
19. SAGENT PHARMS INC
Sagent Pharmaceuticals Inc has filed for 2 different strengths of generic version for Linezolid. Given below are the details of the strengths of this generic introduced by Sagent Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
200MG/100ML (2MG/ML) | solution | Prescription | INTRAVENOUS | AP | Mar 2, 2017 |
600MG/300ML (2MG/ML) | solution | Prescription | INTRAVENOUS | AP | Mar 2, 2017 |
20. SANDOZ
Sandoz Inc has filed for 2 different strengths of generic version for Linezolid. Given below are the details of the strengths of this generic introduced by Sandoz.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG/300ML (2MG/ML) | solution | Prescription | INTRAVENOUS | AP | Jul 16, 2015 |
200MG/100ML (2MG/ML) | solution | Prescription | INTRAVENOUS | AP | Jul 16, 2015 |
Manufacturing Plant Locations New
Sandoz's manufacturing plants are situated in 4 countries - Austria, United States, Spain, India. Given below are the details of these plant locations as well as the firm names of Sandoz as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
Austria |
| |||||
United States |
| |||||
Spain |
| |||||
India |
|
21. TEVA PHARMS
Teva Pharmaceuticals Usa has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Teva Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG/300ML (2MG/ML) | solution | Discontinued | INTRAVENOUS | N/A | Jun 27, 2012 |
22. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG | tablet | Discontinued | ORAL | N/A | May 18, 2015 |
23. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Linezolid. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
600MG | tablet | Prescription | ORAL | AB | Feb 22, 2017 |